Vito D’Ascanio likes the comment:
Vito D’Ascanio Dear Dr. Vito, you are absolutely right. Of course, the theoretical basis for the action of mycotoxin sorbents is better developed than for many other anti-mycotoxin agents. This is not surprising, because the basics of sorption were developed by classical chemistry, and sorption / desorption processes are widely used in industry and agriculture, as well as for scientific purposes ...
Vito D’Ascanio likes the comment:
The main goal is to minimize / avoid mycotoxin effects to consumers, thus we should target/point forward to methods which can achieve this goal. Either prevention from the source or deactivation after contamination. This will involve intense research on, say, deactivators under different environmental conditions to ascertain the effectiveness. This means it should be tested both in vitro and in vi ...
Vito D’Ascanio likes the comment:
For poultry, I have formulated two mycotoxin binders namely Mycodetox B1 and Mycodetox B2 based on my decade's research on chickens, quails, turkeys and ducks. Both the binders ameliorated the adverse effects of aflatoxicosis in poultry and are equally efficaceous in ameliorating aflatoxicosis in these poultry species.
Dr. Ram Singh Bibyan
Participation in Forum on June 2, 2022
Dear Dr. Marchenkov, thanks for your comment. For the binders we are speaking about a binding mechanism. Dietary supplementation with non-nutritive mycotoxin-adsorbents is by far the most practical and most widely studied method for reducing the effects of mycotoxin exposure. Of course, an effective mycotoxin adsorbent should be a nutritionally inert adsorbent, which when incorporated into contami ...
Participation in Forum on June 1, 2022
Dear Dr. Tamames, thanks for your comment. As I explained and underlined in my talk, one of the drawbacks of the in vitro models is that "no prediction of in vivo results can be ensure". So I agree with you, but I would like to add something more.
Even if in vitro data are not able, so far, to predict in vivo results, they can give us an insight into the mechanism (on the physico-chemical point of ...
Video published on March 26, 2022
Evaluating the effect of a mycotoxin-deactivator can be quite challenging. How should we choose between in vitro and in vivo?
Video published on March 26, 2022
EFSA approved products are a gage of quality, but what exactly are the parameters that are checked for by a mycotoxin-deactivator in EFSA? Answered by Dr. Vito D’Ascanio
Video published on March 26, 2022
As various mycotoxin decontamination and detoxification strategies are available, is it possible to manage mycotoxin contamination by resorting to a physical or thermic treatment? Answered by Dr. Vito D’ Ascanio
This member had joined Engormix
May 30, 2022